Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Booster Innovation Fund (BIF) is a New Zealand-based investment fund focused on early-stage deep tech and life science ventures. Managed by Booster Investment Management Limited, the fund specializes in commercializing intellectual property developed within New Zealand's universities and Crown Research Institutes. Its portfolio includes a diverse array of companies working on biotechnology, medical diagnostics, and advanced materials. BIF is unique in providing retail investors with access to a sector typically restricted to institutional venture capital. The fund is publicly listed on the New Zealand Stock Exchange (NZX) under the ticker BIF. It plays a critical role in the New Zealand innovation ecosystem by providing bridge funding and expertise to high-potential startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Booster Innovation Fund.